NCT05536154 2024-03-19
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase NA Unknown
Clinical Trials
11 trialsNCT04746092 2021-08-16
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
Tel-Aviv Sourasky Medical Center
Unknown
NCT04158414 2019-11-08
Applying PET/MR in Oncology - a Prospective Project
Tel-Aviv Sourasky Medical Center
Phase NA Unknown
NCT04154228 2019-11-06
Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI
Tel-Aviv Sourasky Medical Center
Phase NA Unknown
NCT02526823 2019-04-02
Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma
Shandong Provincial Hospital
Phase 4 Unknown
NCT03765593 2018-12-05
pSS
National Council of Scientific and Technical Research, Argentina
Unknown
NCT03540303 2018-05-30
Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma
Henan Cancer Hospital
Phase 1 Unknown
NCT02488382 2017-10-17
Lonquek for Autologous Stem Cell Mobilization
Sheba Medical Center
Phase 1/2 Unknown
NCT02265497 2017-08-18
Relinfo
Instituto Nacional de Cancer, Brazil
Unknown
NCT03062072 2017-04-07
ECHO
National Cancer Center, Korea
Unknown
NCT01300156 2011-02-21
Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)
National Cancer Center, Korea
Phase 2 Unknown